NP / PA
Harnois, Alexandra
Harnois, Alexandra was paid $398K by Medicaid between Oct 2019 and Sep 2024, across 10 billing codes. Its largest line is 99203, doctor's office visit, new patient (routine) — 27% of everything it billed.
33Billing provider infoHARNOIS, ALEXANDRA
NARRAGANSETT, RI 02882
NARRAGANSETT, RI 02882
33aNPI1063871200assigned 02/16/2016
33bProvider typeNurse Practitioner
28Total paid$398K
24GClaims4,075
24DCodes billed10
24AFirst – last monthOct 2019 – Sep 2024
Compared with peers
Next to other Nurse Practitioner providers in Rhode Island
Rank by total paid#3 of 110
Median peer was paid$14K
This provider vs. median29×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 138 | $28K | |
| 2020 | 503 | $68K | |
| 2021 | 1,757 | $160K | |
| 2022 | 1,542 | $134K | |
| 2023 | 77 | $4K | |
| 2024incomplete | 58 | $3K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 27% | 783 | 536 | $109K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20% | 896 | 671 | $79K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 19% | 365 | 130 | $76K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 17% | 513 | 507 | $69K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 5.7% | 549 | 427 | $23K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 3.6% | 403 | 398 | $14K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3.3% | 162 | 158 | $13K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.7% | 50 | 17 | $7K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.6% | 262 | 160 | $7K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 92 | 42 | $2K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.